BioLineRx Ltd.

Tel Aviv Stock Exchange:BLRX.TA

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

Location

Israel

Market Cap

USD 18.02 M

Share Price

USD 0.01

Avg Daily Volume

10,089,224

Change (1 day)

-4.24%

Change (1 year)

-85.30%

Change (YTD)

-58.18%

BioLineRx Ltd. Total Liabilities for the year ending December 31, 2024: USD 25.45 M

BioLineRx Ltd. Total Liabilities is USD 25.45 M for the year ending December 31, 2024, a -49.81% change year over year. Total liabilities are the total amount of a company's debts and other obligations.

BioLineRx Ltd. Total Liabilities for the year ending December 31, 2023 was USD 50.70 M, a 98.50% change year over year.
BioLineRx Ltd. Total Liabilities for the year ending December 31, 2022 was USD 25.54 M, a 91.99% change year over year.
BioLineRx Ltd. Total Liabilities for the year ending December 31, 2021 was USD 13.30 M, a -47.33% change year over year.
BioLineRx Ltd. Total Liabilities for the year ending December 31, 2020 was USD 25.26 M, a 25.13% change year over year.